-
1
-
-
66549097241
-
Fibroblast growth factor 21: A novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus
-
I. Dostalova, D. Haluzikova, and M. Haluzik Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus Physiol. Res. 58 2009 1 7
-
(2009)
Physiol. Res.
, vol.58
, pp. 1-7
-
-
Dostalova, I.1
Haluzikova, D.2
Haluzik, M.3
-
2
-
-
20444435873
-
FGF-21 as a novel metabolic regulator
-
A. Kharitonenkov, T.L. Shiyanova, A. Koester, A.M. Ford, R. Micanovic, E.J. Galbreath, G.E. Sandusky, L.J. Hammond, J.S. Moyers, R.A. Owens, J. Gromada, J.T. Brozinick, E.D. Hawkins, V.J. Wroblewski, D.S. Li, F. Mehrbod, S.R. Jaskunas, and A.B. Shanafelt FGF-21 as a novel metabolic regulator J. Clin. Invest. 115 2005 1627 1635
-
(2005)
J. Clin. Invest.
, vol.115
, pp. 1627-1635
-
-
Kharitonenkov, A.1
Shiyanova, T.L.2
Koester, A.3
Ford, A.M.4
Micanovic, R.5
Galbreath, E.J.6
Sandusky, G.E.7
Hammond, L.J.8
Moyers, J.S.9
Owens, R.A.10
Gromada, J.11
Brozinick, J.T.12
Hawkins, E.D.13
Wroblewski, V.J.14
Li, D.S.15
Mehrbod, F.16
Jaskunas, S.R.17
Shanafelt, A.B.18
-
3
-
-
45649085226
-
Inhibition of growth hormone signaling by the fasting-induced hormone FGF21
-
T. Inagaki, V.Y. Lin, R. Goetz, M. Mohammadi, D.J. Mangelsdorf, and S.A. Kliewer Inhibition of growth hormone signaling by the fasting-induced hormone FGF21 Cell Metab. 8 2008 77 83
-
(2008)
Cell Metab.
, vol.8
, pp. 77-83
-
-
Inagaki, T.1
Lin, V.Y.2
Goetz, R.3
Mohammadi, M.4
Mangelsdorf, D.J.5
Kliewer, S.A.6
-
4
-
-
33846418834
-
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
-
A. Kharitonenkov, V.J. Wroblewski, A. Koester, Y.F. Chen, C.K. Clutinger, X.T. Tigno, B.C. Hansen, A.B. Shanafelt, and G.J. Etgen The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 Endocrinology 148 2007 774 781
-
(2007)
Endocrinology
, vol.148
, pp. 774-781
-
-
Kharitonenkov, A.1
Wroblewski, V.J.2
Koester, A.3
Chen, Y.F.4
Clutinger, C.K.5
Tigno, X.T.6
Hansen, B.C.7
Shanafelt, A.B.8
Etgen, G.J.9
-
5
-
-
34249686631
-
Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21
-
T. Inagaki, P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, Y. Li, R. Goetz, M. Mohammadi, V. Esser, J.K. Elmquist, R.D. Gerard, S.C. Burgess, R.E. Hammer, D.J. Mangelsdorf, and S.A. Kliewer Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 Cell Metab. 5 2007 415 425
-
(2007)
Cell Metab.
, vol.5
, pp. 415-425
-
-
Inagaki, T.1
Dutchak, P.2
Zhao, G.3
Ding, X.4
Gautron, L.5
Parameswara, V.6
Li, Y.7
Goetz, R.8
Mohammadi, M.9
Esser, V.10
Elmquist, J.K.11
Gerard, R.D.12
Burgess, S.C.13
Hammer, R.E.14
Mangelsdorf, D.J.15
Kliewer, S.A.16
-
6
-
-
84904961213
-
Orphan nuclear receptor nur77 mediates fasting-induced hepatic fibroblast growth factor 21 expression
-
A.K. Min, K.H. Bae, Y.A. Jung, Y.K. Choi, M.J. Kim, J.H. Kim, J.H. Jeon, J.G. Kim, I.K. Lee, and K.G. Park Orphan nuclear receptor nur77 mediates fasting-induced hepatic fibroblast growth factor 21 expression Endocrinology 155 2014 2924 2931
-
(2014)
Endocrinology
, vol.155
, pp. 2924-2931
-
-
Min, A.K.1
Bae, K.H.2
Jung, Y.A.3
Choi, Y.K.4
Kim, M.J.5
Kim, J.H.6
Jeon, J.H.7
Kim, J.G.8
Lee, I.K.9
Park, K.G.10
-
7
-
-
84896838463
-
Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor alpha to regulate metabolic hormone FGF21
-
H. Kim, R. Mendez, Z. Zheng, L. Chang, J. Cai, R. Zhang, and K. Zhang Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor alpha to regulate metabolic hormone FGF21 Endocrinology 155 2014 769 782
-
(2014)
Endocrinology
, vol.155
, pp. 769-782
-
-
Kim, H.1
Mendez, R.2
Zheng, Z.3
Chang, L.4
Cai, J.5
Zhang, R.6
Zhang, K.7
-
8
-
-
84876238033
-
Retinoic acid receptor beta stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice
-
Y. Li, K. Wong, K. Walsh, B. Gao, and M. Zang Retinoic acid receptor beta stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice J. Biol. Chem. 288 2013 10490 10504
-
(2013)
J. Biol. Chem.
, vol.288
, pp. 10490-10504
-
-
Li, Y.1
Wong, K.2
Walsh, K.3
Gao, B.4
Zang, M.5
-
9
-
-
77952334180
-
Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha
-
Y. Wang, L.A. Solt, and T.P. Burris Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha J. Biol. Chem. 285 2010 15668 15673
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 15668-15673
-
-
Wang, Y.1
Solt, L.A.2
Burris, T.P.3
-
10
-
-
17844395201
-
The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma
-
K.T. Chin, H.J. Zhou, C.M. Wong, J.M. Lee, C.P. Chan, B.Q. Qiang, J.G. Yuan, I.O. Ng, and D.Y. Jin The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma Nucleic Acids Res. 33 2005 1859 1873
-
(2005)
Nucleic Acids Res.
, vol.33
, pp. 1859-1873
-
-
Chin, K.T.1
Zhou, H.J.2
Wong, C.M.3
Lee, J.M.4
Chan, C.P.5
Qiang, B.Q.6
Yuan, J.G.7
Ng, I.O.8
Jin, D.Y.9
-
11
-
-
0035873671
-
CREB-H: A novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression
-
Y. Omori, J. Imai, M. Watanabe, T. Komatsu, Y. Suzuki, K. Kataoka, S. Watanabe, A. Tanigami, and S. Sugano CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression Nucleic Acids Res. 29 2001 2154 2162
-
(2001)
Nucleic Acids Res.
, vol.29
, pp. 2154-2162
-
-
Omori, Y.1
Imai, J.2
Watanabe, M.3
Komatsu, T.4
Suzuki, Y.5
Kataoka, K.6
Watanabe, S.7
Tanigami, A.8
Sugano, S.9
-
12
-
-
79960110157
-
The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism
-
J.H. Lee, P. Giannikopoulos, S.A. Duncan, J. Wang, C.T. Johansen, J.D. Brown, J. Plutzky, R.A. Hegele, L.H. Glimcher, and A.H. Lee The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism Nat. Med. 17 2011 812 815
-
(2011)
Nat. Med.
, vol.17
, pp. 812-815
-
-
Lee, J.H.1
Giannikopoulos, P.2
Duncan, S.A.3
Wang, J.4
Johansen, C.T.5
Brown, J.D.6
Plutzky, J.7
Hegele, R.A.8
Glimcher, L.H.9
Lee, A.H.10
-
13
-
-
0033607176
-
Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes
-
M. Foretz, C. Guichard, P. Ferre, and F. Foufelle Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes Proc. Natl. Acad. Sci. U.S.A. 96 1999 12737 12742
-
(1999)
Proc. Natl. Acad. Sci. U.S.A.
, vol.96
, pp. 12737-12742
-
-
Foretz, M.1
Guichard, C.2
Ferre, P.3
Foufelle, F.4
-
14
-
-
84878806915
-
CAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis
-
A.K. Min, J.Y. Jeong, Y. Go, Y.K. Choi, Y.D. Kim, I.K. Lee, and K.G. Park CAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis Diabetologia 56 2013 412 422
-
(2013)
Diabetologia
, vol.56
, pp. 412-422
-
-
Min, A.K.1
Jeong, J.Y.2
Go, Y.3
Choi, Y.K.4
Kim, Y.D.5
Lee, I.K.6
Park, K.G.7
-
15
-
-
80052273194
-
The roles of ER stress and P450 2E1 in CCl(4)-induced steatosis
-
G.H. Lee, B. Bhandary, E.M. Lee, J.K. Park, K.S. Jeong, I.K. Kim, H.R. Kim, and H.J. Chae The roles of ER stress and P450 2E1 in CCl(4)-induced steatosis Int. J. Biochem. Cell Biol. 43 2011 1469 1482
-
(2011)
Int. J. Biochem. Cell Biol.
, vol.43
, pp. 1469-1482
-
-
Lee, G.H.1
Bhandary, B.2
Lee, E.M.3
Park, J.K.4
Jeong, K.S.5
Kim, I.K.6
Kim, H.R.7
Chae, H.J.8
-
16
-
-
0026736464
-
Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo
-
E. Busse, G. Zimmer, B. Schopohl, and B. Kornhuber Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo Arzneimittelforschung 42 1992 829 831
-
(1992)
Arzneimittelforschung
, vol.42
, pp. 829-831
-
-
Busse, E.1
Zimmer, G.2
Schopohl, B.3
Kornhuber, B.4
-
17
-
-
0030696877
-
Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization
-
D. Han, G. Handelman, L. Marcocci, C.K. Sen, S. Roy, H. Kobuchi, H.J. Tritschler, L. Flohe, and L. Packer Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization Biofactors 6 1997 321 338
-
(1997)
Biofactors
, vol.6
, pp. 321-338
-
-
Han, D.1
Handelman, G.2
Marcocci, L.3
Sen, C.K.4
Roy, S.5
Kobuchi, H.6
Tritschler, H.J.7
Flohe, L.8
Packer, L.9
-
18
-
-
0029154990
-
Uptake and distribution of N-acetylcysteine in mice: Tissue-specific effects on glutathione concentrations
-
L.I. McLellan, A.D. Lewis, D.J. Hall, J.D. Ansell, and C.R. Wolf Uptake and distribution of N-acetylcysteine in mice: tissue-specific effects on glutathione concentrations Carcinogenesis 16 1995 2099 2106
-
(1995)
Carcinogenesis
, vol.16
, pp. 2099-2106
-
-
McLellan, L.I.1
Lewis, A.D.2
Hall, D.J.3
Ansell, J.D.4
Wolf, C.R.5
-
19
-
-
27644516440
-
Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex
-
J.H. Suh, R. Moreau, S.H. Heath, and T.M. Hagen Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex Redox Rep. 10 2005 52 60
-
(2005)
Redox Rep.
, vol.10
, pp. 52-60
-
-
Suh, J.H.1
Moreau, R.2
Heath, S.H.3
Hagen, T.M.4
-
20
-
-
0029031443
-
Thioctic (lipoic) acid: A therapeutic metal-chelating antioxidant?
-
P. Ou, H.J. Tritschler, and S.P. Wolff Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem. Pharmacol. 50 1995 123 126
-
(1995)
Biochem. Pharmacol.
, vol.50
, pp. 123-126
-
-
Ou, P.1
Tritschler, H.J.2
Wolff, S.P.3
-
21
-
-
0037332176
-
Alpha lipoic acid changes iron uptake and storage in lens epithelial cells
-
M. Goralska, R. Dackor, B. Holley, and M.C. McGahan Alpha lipoic acid changes iron uptake and storage in lens epithelial cells Exp. Eye Res. 76 2003 241 248
-
(2003)
Exp. Eye Res.
, vol.76
, pp. 241-248
-
-
Goralska, M.1
Dackor, R.2
Holley, B.3
McGahan, M.C.4
-
22
-
-
79951726550
-
Evidence that alpha-lipoic acid inhibits NF-kappaB activation independent of its antioxidant function
-
Z. Ying, T. Kampfrath, Q. Sun, S. Parthasarathy, and S. Rajagopalan Evidence that alpha-lipoic acid inhibits NF-kappaB activation independent of its antioxidant function Inflamm. Res. 60 2011 219 225
-
(2011)
Inflamm. Res.
, vol.60
, pp. 219-225
-
-
Ying, Z.1
Kampfrath, T.2
Sun, Q.3
Parthasarathy, S.4
Rajagopalan, S.5
-
23
-
-
37549047574
-
Alpha-lipoic acid inhibits TNF-alpha induced NF-kappa B activation through blocking of MEKK1-MKK4-IKK signaling cascades
-
C.K. Lee, E.Y. Lee, Y.G. Kim, S.H. Mun, H.B. Moon, and B. Yoo Alpha-lipoic acid inhibits TNF-alpha induced NF-kappa B activation through blocking of MEKK1-MKK4-IKK signaling cascades Int. Immunopharmacol. 8 2008 362 370
-
(2008)
Int. Immunopharmacol.
, vol.8
, pp. 362-370
-
-
Lee, C.K.1
Lee, E.Y.2
Kim, Y.G.3
Mun, S.H.4
Moon, H.B.5
Yoo, B.6
-
24
-
-
56249123934
-
The "rejuvenatory" impact of lipoic acid on mitochondrial function in aging rats may reflect induction and activation of PPAR-gamma coactivator-1alpha
-
M.F. McCarty, J. Barroso-Aranda, and F. Contreras The "rejuvenatory" impact of lipoic acid on mitochondrial function in aging rats may reflect induction and activation of PPAR-gamma coactivator-1alpha Med. Hypotheses 72 2009 29 33
-
(2009)
Med. Hypotheses
, vol.72
, pp. 29-33
-
-
McCarty, M.F.1
Barroso-Aranda, J.2
Contreras, F.3
-
25
-
-
56149098763
-
Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways
-
K.G. Park, A.K. Min, E.H. Koh, H.S. Kim, M.O. Kim, H.S. Park, Y.D. Kim, T.S. Yoon, B.K. Jang, J.S. Hwang, J.B. Kim, H.S. Choi, J.Y. Park, I.K. Lee, and K.U. Lee Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways Hepatology 48 2008 1477 1486
-
(2008)
Hepatology
, vol.48
, pp. 1477-1486
-
-
Park, K.G.1
Min, A.K.2
Koh, E.H.3
Kim, H.S.4
Kim, M.O.5
Park, H.S.6
Kim, Y.D.7
Yoon, T.S.8
Jang, B.K.9
Hwang, J.S.10
Kim, J.B.11
Choi, H.S.12
Park, J.Y.13
Lee, I.K.14
Lee, K.U.15
-
26
-
-
57349098220
-
Fibroblast growth factor 21 corrects obesity in mice
-
T. Coskun, H.A. Bina, M.A. Schneider, J.D. Dunbar, C.C. Hu, Y. Chen, D.E. Moller, and A. Kharitonenkov Fibroblast growth factor 21 corrects obesity in mice Endocrinology 149 2008 6018 6027
-
(2008)
Endocrinology
, vol.149
, pp. 6018-6027
-
-
Coskun, T.1
Bina, H.A.2
Schneider, M.A.3
Dunbar, J.D.4
Hu, C.C.5
Chen, Y.6
Moller, D.E.7
Kharitonenkov, A.8
-
27
-
-
84864600846
-
Fibroblast growth factor 21: A novel metabolic regulator
-
J.A. Seo, and N.H. Kim Fibroblast growth factor 21: a novel metabolic regulator Diabetes Metab. J. 36 2012 26 28
-
(2012)
Diabetes Metab. J.
, vol.36
, pp. 26-28
-
-
Seo, J.A.1
Kim, N.H.2
-
28
-
-
69249093921
-
Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity
-
E.D. Berglund, C.Y. Li, H.A. Bina, S.E. Lynes, M.D. Michael, A.B. Shanafelt, A. Kharitonenkov, and D.H. Wasserman Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity Endocrinology 150 2009 4084 4093
-
(2009)
Endocrinology
, vol.150
, pp. 4084-4093
-
-
Berglund, E.D.1
Li, C.Y.2
Bina, H.A.3
Lynes, S.E.4
Michael, M.D.5
Shanafelt, A.B.6
Kharitonenkov, A.7
Wasserman, D.H.8
-
29
-
-
84883481988
-
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
-
G. Gaich, J.Y. Chien, H. Fu, L.C. Glass, M.A. Deeg, W.L. Holland, A. Kharitonenkov, T. Bumol, H.K. Schilske, and D.E. Moller The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes Cell Metab. 18 2013 333 340
-
(2013)
Cell Metab.
, vol.18
, pp. 333-340
-
-
Gaich, G.1
Chien, J.Y.2
Fu, H.3
Glass, L.C.4
Deeg, M.A.5
Holland, W.L.6
Kharitonenkov, A.7
Bumol, T.8
Schilske, H.K.9
Moller, D.E.10
-
30
-
-
84879187565
-
LY2405319, an engineered FGF21 variant, improves the metabolic status of diabetic monkeys
-
A.C. Adams, C.A. Halstead, B.C. Hansen, A.R. Irizarry, J.A. Martin, S.R. Myers, V.L. Reynolds, H.W. Smith, V.J. Wroblewski, and A. Kharitonenkov LY2405319, an engineered FGF21 variant, improves the metabolic status of diabetic monkeys PLoS One 8 2013 e65763
-
(2013)
PLoS One
, vol.8
, pp. 65763
-
-
Adams, A.C.1
Halstead, C.A.2
Hansen, B.C.3
Irizarry, A.R.4
Martin, J.A.5
Myers, S.R.6
Reynolds, V.L.7
Smith, H.W.8
Wroblewski, V.J.9
Kharitonenkov, A.10
-
31
-
-
34249711964
-
Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states
-
M.K. Badman, P. Pissios, A.R. Kennedy, G. Koukos, J.S. Flier, and E. Maratos-Flier Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states Cell Metab. 5 2007 426 437
-
(2007)
Cell Metab.
, vol.5
, pp. 426-437
-
-
Badman, M.K.1
Pissios, P.2
Kennedy, A.R.3
Koukos, G.4
Flier, J.S.5
Maratos-Flier, E.6
-
32
-
-
34447265235
-
PPARalpha is a key regulator of hepatic FGF21
-
T. Lundasen, M.C. Hunt, L.M. Nilsson, S. Sanyal, B. Angelin, S.E. Alexson, and M. Rudling PPARalpha is a key regulator of hepatic FGF21 Biochem. Biophys. Res. Commun. 360 2007 437 440
-
(2007)
Biochem. Biophys. Res. Commun.
, vol.360
, pp. 437-440
-
-
Lundasen, T.1
Hunt, M.C.2
Nilsson, L.M.3
Sanyal, S.4
Angelin, B.5
Alexson, S.E.6
Rudling, M.7
-
33
-
-
37249059359
-
PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes
-
Y.S. Seo, J.H. Kim, N.Y. Jo, K.M. Choi, S.H. Baik, J.J. Park, J.S. Kim, K.S. Byun, Y.T. Bak, C.H. Lee, A. Kim, and J.E. Yeon PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes J. Gastroenterol. Hepatol. 23 2008 102 109
-
(2008)
J. Gastroenterol. Hepatol.
, vol.23
, pp. 102-109
-
-
Seo, Y.S.1
Kim, J.H.2
Jo, N.Y.3
Choi, K.M.4
Baik, S.H.5
Park, J.J.6
Kim, J.S.7
Byun, K.S.8
Bak, Y.T.9
Lee, C.H.10
Kim, A.11
Yeon, J.E.12
-
34
-
-
84869002483
-
Metformin stimulates FGF21 expression in primary hepatocytes
-
E.B. Nygaard, S.G. Vienberg, C. Orskov, H.S. Hansen, and B. Andersen Metformin stimulates FGF21 expression in primary hepatocytes Exp. Diabetes Res. 2012 2012 465282
-
(2012)
Exp. Diabetes Res.
, vol.2012
, pp. 465282
-
-
Nygaard, E.B.1
Vienberg, S.G.2
Orskov, C.3
Hansen, H.S.4
Andersen, B.5
-
35
-
-
84885383560
-
Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation
-
K.H. Kim, Y.T. Jeong, S.H. Kim, H.S. Jung, K.S. Park, H.Y. Lee, and M.S. Lee Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation Biochem. Biophys. Res. Commun. 440 2013 76 81
-
(2013)
Biochem. Biophys. Res. Commun.
, vol.440
, pp. 76-81
-
-
Kim, K.H.1
Jeong, Y.T.2
Kim, S.H.3
Jung, H.S.4
Park, K.S.5
Lee, H.Y.6
Lee, M.S.7
-
36
-
-
3142677140
-
Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase
-
M.S. Kim, J.Y. Park, C. Namkoong, P.G. Jang, J.W. Ryu, H.S. Song, J.Y. Yun, I.S. Namgoong, J. Ha, I.S. Park, I.K. Lee, B. Viollet, J.H. Youn, H.K. Lee, and K.U. Lee Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase Nat. Med. 10 2004 727 733
-
(2004)
Nat. Med.
, vol.10
, pp. 727-733
-
-
Kim, M.S.1
Park, J.Y.2
Namkoong, C.3
Jang, P.G.4
Ryu, J.W.5
Song, H.S.6
Yun, J.Y.7
Namgoong, I.S.8
Ha, J.9
Park, I.S.10
Lee, I.K.11
Viollet, B.12
Youn, J.H.13
Lee, H.K.14
Lee, K.U.15
-
37
-
-
19744372144
-
Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle
-
W.J. Lee, K.H. Song, E.H. Koh, J.C. Won, H.S. Kim, H.S. Park, M.S. Kim, S.W. Kim, K.U. Lee, and J.Y. Park Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle Biochem. Biophys. Res. Commun. 332 2005 885 891
-
(2005)
Biochem. Biophys. Res. Commun.
, vol.332
, pp. 885-891
-
-
Lee, W.J.1
Song, K.H.2
Koh, E.H.3
Won, J.C.4
Kim, H.S.5
Park, H.S.6
Kim, M.S.7
Kim, S.W.8
Lee, K.U.9
Park, J.Y.10
-
38
-
-
84914110555
-
Physiological effect and therapeutic application of alpha lipoic acid
-
S. Park, U. Karunakaran, N.H. Jeoung, J.H. Jeon, and I.K. Lee Physiological effect and therapeutic application of alpha lipoic acid Curr. Med. Chem. 21 2014 3636 3645
-
(2014)
Curr. Med. Chem.
, vol.21
, pp. 3636-3645
-
-
Park, S.1
Karunakaran, U.2
Jeoung, N.H.3
Jeon, J.H.4
Lee, I.K.5
-
39
-
-
64549088894
-
Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion
-
J.A. Butler, T.M. Hagen, and R. Moreau Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion Arch. Biochem. Biophys. 485 2009 63 71
-
(2009)
Arch. Biochem. Biophys.
, vol.485
, pp. 63-71
-
-
Butler, J.A.1
Hagen, T.M.2
Moreau, R.3
-
40
-
-
78650694937
-
Effects of alpha-lipoic acid on body weight in obese subjects
-
E.H. Koh, W.J. Lee, S.A. Lee, E.H. Kim, E.H. Cho, E. Jeong, D.W. Kim, M.S. Kim, J.Y. Park, K.G. Park, H.J. Lee, I.K. Lee, S. Lim, H.C. Jang, K.H. Lee, and K.U. Lee Effects of alpha-lipoic acid on body weight in obese subjects Am. J. Med. 124 85 2011 e81 e88
-
(2011)
Am. J. Med.
, vol.124
, Issue.85
, pp. 81-e88
-
-
Koh, E.H.1
Lee, W.J.2
Lee, S.A.3
Kim, E.H.4
Cho, E.H.5
Jeong, E.6
Kim, D.W.7
Kim, M.S.8
Park, J.Y.9
Park, K.G.10
Lee, H.J.11
Lee, I.K.12
Lim, S.13
Jang, H.C.14
Lee, K.H.15
Lee, K.U.16
-
41
-
-
75749093374
-
A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus
-
Z.X. Poh, and K.P. Goh A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus Endocr. Metab. Immune Disord. Drug Targets 9 2009 392 398
-
(2009)
Endocr. Metab. Immune Disord. Drug Targets
, vol.9
, pp. 392-398
-
-
Poh, Z.X.1
Goh, K.P.2
-
42
-
-
0030884244
-
Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy
-
D. Ziegler, and F.A. Gries Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy Diabetes 46 Suppl. 2 1997 S62 S66
-
(1997)
Diabetes
, vol.46
, pp. 62-S66
-
-
Ziegler, D.1
Gries, F.A.2
|